Updated: Sep 25, 2009
Ankle injuries are the most common injuries incurred during sports and recreational activities. They are particularly common in sports such as basketball, soccer, hiking,1 volleyball, ice skating, or other activities performed on uneven surfaces. About 81% of ankle injuries are ankle sprains.1 In the United States, the frequency of ankle sprains is estimated to be between 1-10 million per year, and approximately 20% of all sports injuries.5,6
The bones involved in the ankle joint are the tibia and the fibula superiorly, which together form a mortise, and the talus inferiorly. The talus, one of the 2 hind foot bones fits in the mortise formed by the tibia and fibula. The articular surface of the talus is called the trochlea, and it is wider anteriorly than it is posteriorly. At the level of the ankle joint, the tibia and fibula are connected anteriorly by the anterior inferior tibiofibular ligament and posteriorly by the posterior tibiofibular ligament. The interosseous membrane connects the tibia and fibula along their length. Laterally, the ankle is stabilized by the anterior talofibular ligament, the calcaneofibular ligament, and the posterior tibiofibular ligament. The deltoid ligament provides stability to the medial aspect of the ankle. Movement at the ankle joint occurs in the vertical plane only, as plantarflexion and dorsiflexion. Inversion and eversion occur at the subtalar joint.5
Ankle sprains are classified into 3 grades per the West Point Sprain Grading System, as follows:
Inversion injuries occur at a rate of 1 per 10,000 people per day, which adds up to about 23,000 injuries per day in the United States.10 Injury to the dominant ankle is 2-3 times more likely than injury to the nondominant ankle.
Ankle sprains are generally considered benign and self-limiting. However, ankle sprains can cause significant morbidity, and they do represent a significant health problem, accounting for an estimated 1.6 million physician office visits and 8000 hospitalizations per year.10,11 As many as 32% of top athletes with an ankle sprain will experience recurrent sprains after 1 year.12,14 Approximately 30-70% of those experiencing a first-time ankle sprain will develop chronic ankle instability.10 One systematic literature review found that 33-53% of patients had residual symptoms at 36.2 months,12 and many patients reported residual symptoms as long as 3 years after their initial ED visit.12 These symptoms include functional instability, mechanical instability, chronic pain, stiffness, and recurrent or chronic swelling.
Eversion injuries are more likely to result in persistent pain or chronic instability.
Syndesmotic sprains and rupture of the superior peroneal retinaculum tend to be associated with a prolonged recovery course and a higher incidence of residual symptoms, including ankle instability and chronic pain.8,9
Female athletes are 25% more likely to sustain ankle injuries than male athletes. Female basketball players are at a higher risk of a first-time inversion injury than those participating in other sports.2 Soccer and volleyball are other leading causes of ankle sprains in high school and college female athletes.3,10 Some studies attribute a higher incidence of ankle injuries in high school football, basketball, and soccer players.1,3,4 Other studies conclude that there seems to be no difference in the risk of suffering and ankle sprain in college men involved in basketball, soccer, or football.2
Ankle injuries primarily involve young people, perhaps because of greater participation in physically demanding recreational activities and sports. The risk of a first-time inversion injury is similar between high school and college athletes.2 The most common ankle injuries were ligament sprains with incomplete tears.4 There is a higher incidence of ankle injuries during competition than during practice.4 Fractures and tendon ruptures occur more often in older adults. Salter-Harris fractures occur in children and teenagers with open growth plates.
Assessment of all orthopedic injuries should include the following:
Fractures, Ankle
Fractures, Foot
Tendonitis
Tenosynovitis
Achilles tendon rupture
Peroneal tendon subluxation
Septic joint
For patient comfort, all ankle injuries should be placed in a splint prior to transport to the ED.
The goals of therapy are to reduce pain and to prevent complications.
With analgesic and anti-inflammatory properties, NSAIDs are the ideal agents for treating ankle injuries. Acetaminophen with or without an opiate analgesic may be added to NSAID therapy (or used as a substitute).
Usually DOC for treatment of mild to moderate pain, if no contraindications exist. Inhibits inflammatory reactions and pain by decreasing activity of enzyme cyclooxygenase, resulting in the inhibition of prostaglandin synthesis.
200-400 mg PO q4-6h while symptoms persist; not to exceed 3.2 g/d
<6 months: Not established
6 months to 12 years: 20-40 mg/kg/d PO divided tid/qid
>12 years: Administer as in adults
Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy
Used for the relief of mild to moderate pain and inflammation.
Administer small doses initially to patients with small body size, elderly patients, and those with renal or liver disease.
Doses higher than 75 mg do not increase its therapeutic effects. Administer high doses with caution, and closely observe patients for response.
25-50 mg PO q6-8h prn; not to exceed 300 mg/d
<3 months: Not established
3 months to 12 years: 0.1–1 mg/kg PO q6-8h
>12 years: Administer as in adults
Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy
For relief of mild to moderate pain; inhibits inflammatory reactions and pain by decreasing activity of cyclooxygenase, which results in a decrease of prostaglandin synthesis.
500 mg PO followed by 250 mg PO q6-8h; not to exceed 1.25 g/d
<2 years: Not established
>2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d
Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug
Pain control is essential to quality patient care. Analgesics ensure patient comfort, promote pulmonary toilet, and enable physical therapy regimens. Many analgesics have sedating properties that are beneficial for patients who have sustained injuries.
DOC for pain in patients with documented hypersensitivity to aspirin or NSAIDs, with upper GI disease, or who are taking oral anticoagulants.
325-650 mg PO q4-6h or 1,000 mg tid/qid; not to exceed 4 g/d
<12 years: 10-15 mg/kg/dose PO q4-6h prn; not to exceed 2.6 g/d
>12 years: 325-650 mg PO q4h; not to exceed 5 doses/d
Rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity
Documented hypersensitivity; known G-6-PD deficiency
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Hepatotoxicity possible in chronic alcoholics following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; acetaminophen is contained in many OTC products, and combined use with these products may result in cumulative doses exceeding recommended maximum dose
Drug combination indicated for the treatment of mild to moderate pain.
30-60 mg/dose based on codeine content PO q4-6h or 1-2 tab PO q4h; not to exceed 12 tab/d
0.5-1 mg/kg/dose based on codeine PO q4-6h; 10-15 mg/kg/dose based on acetaminophen content; not to exceed 2.6 g/d acetaminophen
Toxicity of codeine increases with CNS depressants, tricyclic antidepressants, MAO inhibitors, neuromuscular blockers, CNS depressants, phenothiazines, and narcotic analgesics
Rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity of acetaminophen
Documented hypersensitivity
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Caution in patients dependent on opiates because this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction
Drug combination indicated for moderate to severe pain.
1-2 tab PO q4-6h prn pain
<12 years: 10-15 mg/kg/dose acetaminophen PO q4-6h prn; not to exceed 2.6 g/d of acetaminophen
>12 years: 750 mg acetaminophen PO q4h; not to exceed 5 doses/d; single dose should not exceed 10 mg of hydrocodone bitartrate
Coadministration with phenothiazines may decrease analgesic effects; toxicity increases with CNS depressants or tricyclic antidepressants
Documented hypersensitivity; high-altitude cerebral edema (HACE); elevated intracranial pressure (ICP)
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Tablets contain metabisulfite, which may cause hypersensitivity; caution in patients dependent on opiates because this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction
Fong DT, Man CY, Yung PS, Cheung SY, Chan KM. Sport-related ankle injuries attending an accident and emergency department. Injury. Oct 2008;39(10):1222-7. [Medline].
Beynnon BD, Vacek PM, Murphy D, Alosa D, Paller D. First-time inversion ankle ligament trauma: the effects of sex, level of competition, and sport on the incidence of injury. Am J Sports Med. Oct 2005;33(10):1485-91. [Medline].
Fernandez WG, Yard EE, Comstock RD. Epidemiology of lower extremity injuries among U.S. high school athletes. Acad Emerg Med. Jul 2007;14(7):641-5. [Medline].
Nelson AJ, Collins CL, Yard EE, Fields SK, Comstock RD. Ankle injuries among United States high school sports athletes, 2005-2006. J Athl Train. Jul-Sep 2007;42(3):381-7. [Medline].
Wexler RK. The injured ankle. Am Fam Physician. Feb 1 1998;57(3):474-80. [Medline].
Ivins D. Acute ankle sprain: an update. Am Fam Physician. Nov 15 2006;74(10):1714-20. [Medline].
Dias LS. The lateral ankle sprain: an experimental study. J Trauma. Apr 1979;19(4):266-9. [Medline].
Jones MH, Amendola A. Syndesmosis sprains of the ankle: a systematic review. Clin Orthop Relat Res. Feb 2007;455:173-5. [Medline].
Williams GN, Jones MH, Amendola A. Syndesmotic ankle sprains in athletes. Am J Sports Med. Jul 2007;35(7):1197-207. [Medline].
McKeon PO, Mattacola CG. Interventions for the prevention of first time and recurrent ankle sprains. Clin Sports Med. Jul 2008;27(3):371-82, viii. [Medline].
Praemer A, Furner S, Rice D. Musculoskeletal conditions in the Unites States. American Academy of Orthopedic Surgeons. 1999;173-5.
van Rijn RM, van Os AG, Bernsen RM, Luijsterburg PA, Koes BW, Bierma-Zeinstra SM. What is the clinical course of acute ankle sprains? A systematic literature review. Am J Med. Apr 2008;121(4):324-331.e6. [Medline].
Brown TD, Johnston RC, Saltzman CL, Marsh JL, Buckwalter JA. Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma. Nov-Dec 2006;20(10):739-44. [Medline].
Linde F, Hvass I, Jurgensen U, Madsen F. Early mobilizing treatment in lateral ankle sprains. Course and risk factors for chronic painful or function-limiting ankle. Scand J Rehabil Med. 1986;18(1):17-21. [Medline].
Refshauge KM, Kilbreath SL, Raymond J. Deficits in detection of inversion and eversion movements among subjects with recurrent ankle sprains. J Orthop Sports Phys Ther. Apr 2003;33(4):166-73; discussion 173-6. [Medline].
Stiell IG, Greenberg GH, McKnight RD, Nair RC, McDowell I, Reardon M. Decision rules for the use of radiography in acute ankle injuries. Refinement and prospective validation. JAMA. Mar 3 1993;269(9):1127-32. [Medline].
Bachmann LM, Kolb E, Koller MT, Steurer J, ter Riet G. Accuracy of Ottawa ankle rules to exclude fractures of the ankle and mid-foot: systematic review. BMJ. Feb 22 2003;326(7386):417. [Medline].
Stiell IG, Greenberg GH, McKnight RD, Nair RC, McDowell I, Worthington JR. A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emerg Med. Apr 1992;21(4):384-90. [Medline].
Wester JU, Jespersen SM, Nielsen KD, Neumann L. Wobble board training after partial sprains of the lateral ligaments of the ankle: a prospective randomized study. J Orthop Sports Phys Ther. May 1996;23(5):332-6. [Medline].
Aiken AB, Pelland L, Brison R, Pickett W, Brouwer B. Short-term natural recovery of ankle sprains following discharge from emergency departments. J Orthop Sports Phys Ther. Sep 2008;38(9):566-71. [Medline].
Thacker SB, Stroup DF, Branche CM, Gilchrist J, Goodman RA, Weitman EA. The prevention of ankle sprains in sports. A systematic review of the literature. Am J Sports Med. Nov-Dec 1999;27(6):753-60. [Medline].
Handoll HH, Rowe BH, Quinn KM, de Bie R. Interventions for preventing ankle ligament injuries. Cochrane Database Syst Rev. 2001;(3):CD000018. [Medline].
Verhagen E, van der Beek A, Twisk J, Bouter L, Bahr R, van Mechelen W. The effect of a proprioceptive balance board training program for the prevention of ankle sprains: a prospective controlled trial. Am J Sports Med. Sep 2004;32(6):1385-93. [Medline].
Verhagen RA, de Keizer G, van Dijk CN. Long-term follow-up of inversion trauma of the ankle. Arch Orthop Trauma Surg. 1995;114(2):92-6. [Medline].
Dowling S, Spooner CH, Liang Y, Dryden DM, Friesen C, Klassen TP. Accuracy of Ottawa Ankle Rules to exclude fractures of the ankle and midfoot in children: a meta-analysis. Acad Emerg Med. Apr 2009;16(4):277-87. [Medline].
Lamb SE, Marsh J, Hutton J, Nakash R, Cooke MW, on behalf of the Collaborative Ankle Support Trial (CAST Group). Mechanical supports for acute, severe ankle sprain: a pragmatic, multicentre, randomised controlled trial. Lancet. 2008;373:575-81.
Maffulli N, Ferran NA. Management of acute and chronic ankle instability. J Am Acad Orthop Surg. Oct 2008;16(10):608-15. [Medline].
Kerkhoffs GM, Handoll HH, de Bie R, Rowe BH, Struijs PA. Surgical versus conservative treatment for acute injuries of the lateral ligament complex of the ankle in adults. Cochrane Database Syst Rev. Apr 18 2007;CD000380. [Medline].
ankle injury, soft tissue ankle injury, soft-tissue ankle injury, ankle sprain, sprained ligament, twisted ankle, Ottawa ankle rules, sports-related ankle injury, ankle injuries, anterior talofibular ligament rupture, ATFL rupture, recurrent ankle sprain, calcaneofibular ligament rupture, CFL rupture, posterior talofibular ligament rupture, PTFL rupture, distal tibiofibular syndesmotic rupture, superior peroneal retinaculum rupture, ankle ligaments, inversion ankle injury
Mircea Muresanu, MD,, Resident Physician, Department of Emergency Medicine, State University of New York Downstate Medical Center, Brooklyn
Mircea Muresanu, MD, is a member of the following medical societies: American College of Emergency Physicians and Emergency Medicine Residents Association
Disclosure: Nothing to disclose.
Antonia Quinn, DO, Assistant Professor, Assistant Residency Director, Department of Emergency Medicine, State University of New York Downstate Medical Center/Kings County Hospital Center; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Antonia Quinn, DO is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Edward Bessman, MD, Chairman, Department of Emergency Medicine, John Hopkins Bayview Medical Center; Assistant Professor, Department of Emergency Medicine, Johns Hopkins University
Edward Bessman, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment
Tom Scaletta, MD, President, Emergency Excellence (EmEx) (www.emergencyexcellence.com); Assistant Professor of Emergency Medicine, Rush Medical College, Cook County Hospital; Chairperson, Department of Emergency Medicine, Edward Hospital; Past-President, American Academy of Emergency Medicine
Tom Scaletta, MD is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Rick Kulkarni, MD, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: WebMD Salary Employment